Anti-Human CD33 Recombinant Antibody(Vadastuximab)
-
产品编号
YR1410
-
别名
科研级 Vadastuximab ( 伐达妥昔单抗 ), Anti-CD33 Recombinant Antibody, Research Grade Vadastuximab
-
规格
- 1mg
- 5mg
Alias | 科研级 Vadastuximab ( 伐达妥昔单抗 ), Anti-CD33 Recombinant Antibody, Research Grade Vadastuximab |
Catalog Number | YR1410 |
Molecular Name | Vadastuximab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Vadastuximab talirine or SGN-CD33A is an antibody-drug conjugate or ADC directed to CD33 or Siglec-3 is a transmembrane receptor expressed on cells of myeloid lineage. The trial drug, being developed by Seattle Genetics and currently in clinical trials, is designed for the treatment of acute myeloid leukemia (AML). |
CAS Number | 1436390-63-4 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD33[Homo sapiens] |